Quince Therapeutics, Inc. (QNCX) ownership: Top institutional holder: Nantahala Capital Management, LLC ($8.95M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Nantahala Capital Management, LLC | 2672429.00 | $8.95M | 2025-12-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2250000.00 | $7.54M | 2025-12-31 |
| VANGUARD GROUP INC | 2084015.00 | $6.98M | 2025-12-31 |
| Almitas Capital LLC | 930134.00 | $3.12M | 2025-12-31 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 858711.00 | $2.88M | 2025-12-31 |
| RENAISSANCE TECHNOLOGIES LLC | 538100.00 | $1.80M | 2025-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 523899.00 | $1.76M | 2025-12-31 |
| JANE STREET GROUP, LLC | 521072.00 | $1.75M | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 |
Back to QNCX overview · QNCX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.